Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;5(5):436-444.
doi: 10.1002/ame2.12230. Epub 2022 Aug 2.

A review: Systematic research approach on toxicity model of liver and kidney in laboratory animals

Affiliations
Review

A review: Systematic research approach on toxicity model of liver and kidney in laboratory animals

Abbasali Abbasnezhad et al. Animal Model Exp Med. 2022 Oct.

Abstract

Therapeutic experiments are commonly performed on laboratory animals to investigate the possible mechanism(s) of action of toxic agents as well as drugs or substances under consideration. The use of toxins in laboratory animal models, including rats, is intended to cause toxicity. This study aimed to investigate different models of hepatotoxicity and nephrotoxicity in laboratory animals to help researchers advance their research goals. The current narrative review used databases such as Medline, Web of Science, Scopus, and Embase and appropriate keywords until June 2021. Nephrotoxicity and hepatotoxicity models derived from some toxic agents such as cisplatin, acetaminophen, doxorubicin, some anticancer drugs, and other materials through various signaling pathways are investigated. To understand the models of renal or hepatotoxicity in laboratory animals, we have provided a list of toxic agents and their toxicity procedures in this review.

Keywords: animal; drug toxicity; drug-induced abnormality; liver dysfunction; renal injury.

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

Cited by

References

    1. Cohen SM, Lippard SJ. Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol.2001;67:93‐130 - PubMed
    1. Sadowitz PD, Hubbard BA, Dabrowiak JC, et al. Kinetics of cisplatin binding to cellular DNA and modulations by thiol‐blocking agents and thiol drugs. Drug Metab Dispos. 2002;30:183‐190. - PubMed
    1. El‐Sayyad HI, Ismail MF, Shalaby F, et al. Histopathological effects of cisplatin, doxorubicin and 5‐flurouracil (5‐FU) on the liver of male albino rats. Int J Biol Sci. 2009;5:466. - PMC - PubMed
    1. Karadeniz A, Simsek N, Karakus E, et al. Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin. Oxid Med Cell Longev. 2011;2011:981793. - PMC - PubMed
    1. Fatima S, Yusufi ANK, Mahmood R. Effect of cisplatin on renal brush border membrane enzymes and phosphate transport. Hum Exp Toxicol. 2004;23:547‐554. - PubMed

MeSH terms